Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
OI and Bone Fragility Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 31 | 25 |
|
Hypophosphatasia (HPP) and Osteogenesis Imperfecta (OI) Genetic Panel (2 Day STAT TAT) Machaon Diagnostics United States | 18 | 15 |
|
IFITM5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 95 | 95 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Skeletal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 624 | 349 |
|
Bone Fragility and Fracture Panel PreventionGenetics, part of Exact Sciences United States | 87 | 74 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 110 | 50 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 33 | 26 |
|
Osteogenesis imperfecta, type V Deletion / Duplication test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Osteogenesis imperfecta, type V Comprehensive test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Osteogenesis imperfecta, type V Sequencing test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Osteogenesis imperfecta NGS panel - Dominant & Recessive HNL Genomics Connective Tissue Gene Tests United States | 30 | 24 |
|
Osteogenesis imperfecta core NGS panel HNL Genomics Connective Tissue Gene Tests United States | 5 | 3 |
|
Osteogenesis imperfecta NGS panel - Dominant HNL Genomics Connective Tissue Gene Tests United States | 9 | 7 |
|
Osteogenesis imperfecta Deletion / Duplication panel - Dominant HNL Genomics Connective Tissue Gene Tests United States | 9 | 7 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.